Université de Lorraine, CNRS, CRAN, F-54000 Nancy, France.
Université de Lorraine, CNRS, CRAN, F-54000 Nancy, France.
Adv Drug Deliv Rev. 2019 Jan 1;138:344-357. doi: 10.1016/j.addr.2018.10.013. Epub 2018 Nov 7.
Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor. Despite new knowledges on the genetic characteristics, conventional therapy for GBM, tumor resection followed by radiotherapy and chemotherapy using temozolomide is limited in efficacy due to high rate of recurrence. GBM is indeed one of the most complex and difficult cancer to treat mainly due to its highly invasive properties and the standard treatments are thus rarely curative. Major challenges in the treatment of GBM are the limitation of irreversible brain damage, the infiltrative part of the tumor which is the ultimate cause of recurrence, the difficulty of identifying tumor margins and disseminated tumor cells, and the transport across the blood-brain barrier in order to obtain a sufficient therapeutic effect for pharmalogical agents. Considering these limitations, this review explores the in vivo potential of metal-based nanoparticles for hyperthermia, radiotherapy and photodynamic therapy. This article describes and clearly outlines the recent in vivo advances using innovative therapeutic metallic nanoparticles such as iron oxide, silver, gadolinium and gold nanoparticles.
多形性胶质母细胞瘤(GBM)是最具侵袭性的恶性脑肿瘤。尽管对遗传特征有了新的认识,但由于复发率高,GBM 的常规治疗——肿瘤切除后辅以替莫唑胺放疗和化疗——在疗效上受到限制。GBM 确实是最难治疗的癌症之一,主要是由于其高度侵袭性的特性,而标准治疗很少能治愈。GBM 治疗的主要挑战是不可逆脑损伤的限制、肿瘤的浸润部分,这是复发的最终原因、肿瘤边界和播散的肿瘤细胞的识别困难,以及药物穿过血脑屏障以获得足够的治疗效果的困难。考虑到这些局限性,本综述探讨了金属纳米粒子在热疗、放疗和光动力治疗中的体内潜力。本文描述并明确概述了使用氧化铁、银、钆和金纳米粒子等创新治疗性金属纳米粒子的最新体内进展。
Adv Drug Deliv Rev. 2018-11-7
Int J Nanomedicine. 2014-6-10
ACS Chem Neurosci. 2019-2-19
Future Med Chem. 2019-9-23
Expert Rev Neurother. 2007-4
Exploration (Beijing). 2024-6-26
Drug Deliv Transl Res. 2025-4-21
Adv Healthc Mater. 2025-5
Int J Nanomedicine. 2025-1-16
Front Bioeng Biotechnol. 2024-7-11
ACS Nano. 2024-7-2